您的位置: 首页 > 农业专利 > 详情页

ANTICORPS ANTI-LAP ET LEURS UTILISATIONS
专利权人:
Tilos Therapeutics; Inc.
发明人:
申请号:
EP18797276.5
公开号:
EP3694552A1
申请日:
2018.10.10
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
Provided herein are antibodies which bind to latency-associated peptide (LAP) of TGF-β1 and are characterized by particular functional features, such as binding specifically to LAP-TGFβ1 on cells but not to LAP-TGFβ1 in extracellular matrix, as well as compositions including the same. Also provided are uses of these antibodies in therapeutic applications, such as in the treatment of cancer, and diagnostic applications.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充